Back to results
US 7,119,186 B2Granted
Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
AssigneeAthena Diagnostics, Inc.
InventorShoji Tsuji
Life of this patent
Estimating the term…
Abstract
The present invention provides polynucleotides and proteins, which are involved in early-onset spinocerebellar ataxia with ocular motor apraxia and hypoalbuminemia (EAOH); and methods of using the polynucleotides and/or proteins to treat and/or diagnose EAOH.
Claims8
An isolated polynucleotide, which encodes a protein comprising the amino acid sequence of SEQ ID NO:4.
An isolated polynucleotide, which comprises nucleotides 7 to 1032 of SEQ ID NO:3.
An isolated polynucleotide, which is entirely complementary to nucleotides 7 to 1032 of SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.